Summit Therapeutics (SMMT) Q4 2023 Earnings

20FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.43
-0.96
-0.49
-0.02

Details

Expected EPS
N/A
Actual EPS
-0.05
Surprise EPS
-0.05
Surprise Percent
+∞%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.05 per share for Q4 2023.

0 Comments

Share your thoughts